Cargando…
Recent Advances with Precision Medicine Treatment for Breast Cancer including Triple-Negative Sub-Type
SIMPLE SUMMARY: The progress of next-generation sequencing technologies has raised huge expectations for precision-medicine therapy approaches in breast cancer and triple-negative breast cancer. Targeted therapy strategies such as ICIs, EGFRi, PARPi, ADCs, CD44i, OVs, and GLUT1i are innovative thera...
Autores principales: | Subhan, Md Abdus, Parveen, Farzana, Shah, Hassan, Yalamarty, Satya Siva Kishan, Ataide, Janaína Artem, Torchilin, Valdimir P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137302/ https://www.ncbi.nlm.nih.gov/pubmed/37190133 http://dx.doi.org/10.3390/cancers15082204 |
Ejemplares similares
-
Recent Advances in Tumor Targeting via EPR Effect for Cancer Treatment
por: Subhan, Md Abdus, et al.
Publicado: (2021) -
Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM)
por: Yalamarty, Satya Siva Kishan, et al.
Publicado: (2023) -
Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis
por: Subhan, Md Abdus, et al.
Publicado: (2023) -
Developments in Treatment Methodologies Using Dendrimers for Infectious Diseases
por: Filipczak, Nina, et al.
Publicado: (2021) -
Lipid-Based Drug Delivery Systems in Regenerative Medicine
por: Filipczak, Nina, et al.
Publicado: (2021)